logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Acne Vulgaris

    FiltersReset Filters
    63 results

    • aczone

      (dapsone)
      Allergan, Inc.
      Usage: ACZONE® Gel, 5%, is indicated for the topical treatment of acne vulgaris.

    • aczone

      (dapsone)
      Almirall, LLC
      Usage: ACZONE® (dapsone) Gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

    • adapalene

      (ADAPALENE)
      Alembic Pharmaceuticals Inc.
      Usage: Adapalene gel, 0.3%, is indicated for the topical treatment of acne vulgaris in patients aged 12 and older.

    • adapalene

      (adapalene)
      E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
      Usage: Adapalene cream is indicated for the topical treatment of acne vulgaris.

    • aklief

      (trifarotene)
      Galderma Laboratories, L.P.
      Usage: AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

    • altreno

      (tretinoin)
      Bausch Health US, LLC
      Usage: ALTRENO® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

    • arazlo

      (tazarotene)
      Bausch Health US, LLC
      Usage: ARAZLO® (tazarotene) lotion, 0.045% is indicated for the topical treatment of acne vulgaris in patients aged 9 and older.

    • claravis

      (Isotretinoin)
      Teva Pharmaceuticals USA, Inc.
      Usage: Claravis (isotretinoin capsules) is indicated for the treatment of severe recalcitrant nodular acne in patients unresponsive to conventional therapies. It is reserved for non-pregnant patients due to risks of severe birth defects and may result in prolonged remission after a single 15-20 week course.

    • cleocin t

      (clindamycin phosphate)
      Pharmacia & Upjohn Company LLC
      Usage: CLEOCIN T Topical Solution, Gel, and Lotion are indicated for the treatment of acne vulgaris. Physicians should weigh the potential risks of diarrhea, bloody diarrhea, and pseudomembranous colitis when considering this medication.

    • clindacin p

      (clindamycin phosphate)
      Medimetriks Pharmaceuticals, Inc.
      Usage: Clindacin•P® is indicated for the treatment of acne vulgaris. Physicians should consider the risk of diarrhea and colitis when prescribing and evaluate the appropriateness of other treatments.
      • ...